StockNews.com upgraded shares of HIVE Blockchain Technologies (NASDAQ:HIVE – Free Report) to a sell rating in a research report released on Wednesday. Separately, Canaccord Genuity Group reiterated a buy rating and issued a $7.00 price objective on shares of HIVE Blockchain Technologies in a research report on Wednesday, March 22nd. HIVE Blockchain Technologies Stock Performance […]